Methods and Results We reviewed our experience with 24 children under 2 years of age with dilated congestive cardiomyopathy to determine outcome and potential predictive variables. Clinical, serological, ECG, echocardiographic, hemodynamic, and histological findings were analyzed. Idiopathic cardiomyopathy or myocarditis constituted 29% of the patients presenting with congestive heart failure without structural heart disease. Among these patients, 45% recovered completely, 25% survived with persistent left ventricular dysfunction, and 30% died. All except one of the deaths occurred during the first 2 months after presentation. Poorer outcome and higher mortality were associated with a more severely depressed left ventricular ejection fraction and/or a more spherical left ventricular shape at presentation. Histological D ilated cardiomyopathy (DCM) represents a heterogeneous group of diseases with multiple etiologies united by a common presentation of a dilated, poorly contractile heart, usually accompanied by heart failure. Although specific causes can be identified in some cases such as congenital heart disease or metabolic disease, most cases are idiopathic. At least some of these patients have myocarditis, although clinical diagnosis may be very difficult. 12 The prognosis varies from complete recovery to death and has been reported to be better in patients who present before the age of 2 years. 34 The availability of cardiac transplantation has increased the importance of accurate diagnosis and prognosis. We reviewed our young patients with DCM to identify prognostic factors from echocardiograms, hemodynamics, or histology to improve selection of patients for early transplantation instead of medical management.
Methods Study Population
The study population was limited to patients with either idiopathic congestive cardiomyopathy or myocarditis who pre-evidence of myocardial inflammation was a favorable prognostic indicator, whereas histological evidence of endocardial fibroelastosis was associated with a poor outcome. During the recovery phase, diastolic volume fell rapidly. Ventricular mass was elevated from the earliest observations and fell more slowly, with persistent elevation of the mass-to-volume ratio up to 2 years. Function and contractility improved over the first several months in most patients who recovered, although in occasional patients continued improvement was seen for as long as 2 years after presentation.
Conclusions Histological and echocardiographic features can be used to identify patients at particularly high risk for death. To have any impact on outcome, decisions about cardiac transplantation must be reached rapidly, since almost all deaths occurred within the first 2 months after presentation. Recovery of function is often rapid, but continued improvement may be seen for as long as 2 years. (Circulation. 1994; 90:1310 -1318 Key Words * dilated cardiomyopathy * pediatrics . morbidity * mortality sented within the first 2 years of life. The specific study entrance criteria were presentation to Boston Children's Hospital with congestive heart failure before 2 years of age between 1982 and 1990; dilated, hypocontractile left ventricle on echocardiogram (ejection fraction, <50%); absence of identifiable cause of ventricular dysfunction, including congenital heart disease (eg, left-sided obstructions and coronary artery anomalies), exposure to cardiotoxic agents (eg, anthracyclines), Kawasaki's disease, chronic primary arrhythmias, bacterial sepsis, postischemic injury (asphyxia), and HIV infection. Case finding was performed by search of the computerized echocardiographic database.
Data Collection
The hospital records of each patient were reviewed. The ECG and chest radiograph at presentation, echocardiogram at presentation and during follow-up, hemodynamic data at earliest catheterization (if catheterization was done), results of tissue diagnosis (endomyocardial biopsy or postmortem examination), and clinical outcome were reviewed. From the catheterization records, the following data were obtained when available: mean right atrial pressure, mean pulmonary artery pressure, left ventricular (LV) end-diastolic pressure, and cardiac index (thermodilution or Fick method).
Echocardiographic data were collected using previously described methods.5 13 Subjects under 2 years of age were sedated with 50 to 100 mg/kg chloral hydrate. Sedation was used in older patients as needed. Complete Doppler and two-dimensional echocardiographic examinations were performed using a Diasonics Cardiovue 100, ATL Mark 600, Hewlett-Packard 77020, or Accuson 128 cardiac imager equipped with a transducer appropriate for body size and habitus and recorded on 0.5-in videotape. Standard short-and long-axis views of the LV were recorded to assess regional wall motion and calculate LV mass and volume. In addition, in patients with a circular LV in short-axis views and no evidence of regional wall motion abnormalities, high-speed (100 mm/s) hard-copy two-dimensional echocardiographic-directed Mmode recording of the LV minor axis was obtained simultaneously with the ECG, phonocardiogram, indirect carotid pulse tracing (or axillary pulse tracing in patients <4 years of age), and peripheral blood pressure. Systolic and diastolic blood pressures were obtained as the average of three to six readings using a Dynamap 845 Vital Signs Monitor.
Data Analysis

Outcome Variables
Outcome was assessed in terms of late status with respect to survival and persistence of symptoms referable to the cardiovascular system and/or ventricular dysfunction. Patients who survived, who were symptom free, and in whom ventricular function (ejection fraction, >55%) had fully recovered were classified as having a "good" late outcome, whereas patients who died, had persistent ventricular dysfunction, or had persistent symptoms were classified as having "poor" outcome.
Echocardiographic Determination of LV Mass and Volume
Long-axis four-chamber images of the LV from apical or subxiphoid windows and short-axis images of the LV were digitized using an off-line video digitizing and analysis device (Dextra 200 Analysis System, Dextra Medical Inc). End-diastolic and end-systolic frames were defined as the frames showing the largest and the smallest LV silhouettes, respectively. After calibration, endocardial and epicardial borders of the LV were hand-digitized at end systole and end diastole. The LV mass, end-systolic volume (ESV), and end-diastolic volume (EDV) were calculated according to a modified biapical Simpson's rule, using one long-axis and one short-axis view in orthogonal planes.14"5 LV mass was determined as total epicardial volume minus cavity volume multiplied by specific gravity of myocardium (1.04 g/mL). Ejection fraction was determined as (EDV-ESV)/EDV. The results for ventricular mass and volume were adjusted for body size by dividing by (body surface area)'-5.
M-Mode Measurements
The pulse tracing, the LV endocardial border of the septum, and the endocardial and epicardial borders of the LV posterior wall were hand-digitized using a microcomputer-based digitizing station with custom software. This system is programmed to adjust the tablet sampling rate to 200 Hz, which is adequate to obtain at least 50 nonaliased harmonics at heart rates of < 120 beats per minute. The pulse transmission delay was corrected by electronically aligning the dicrotic notch of the pulse tracing with the first high-frequency component of the second heart sound of the phonocardiogram. End-systolic pressure was calculated from the calibrated pulse tracing as previously described.9-1' To obtain an estimate of LV shape, the LV long-axis dimension was measured from apical fourchamber two-dimensional echocardiographic images at end diastole and at end systole. From the digitized data, the following measurements were obtained throughout ejection by averaging three to six cardiac cycles: LV short-axis diameter, LV posterior wall thickness, and LV pressure. End 
Results
There were a total of 82 patients less than 2 years of age with DCM by echocardiography without structural heart disease who presented during the study time period. The distribution of diagnoses was (1) ischemic damage (30.5%, 25 patients), related to perinatal asphyxia or postresuscitation for primary problems other than heart disease; (2) idiopathic cardiomyopathy or myocarditis (29%, 24 patients); (3) adriamycin cardiomyopathy (11%, 9 patients); (4) Kawasaki cardiomyopathy (8.5%, 7 patients); (5) AIDS (7.5%, 6 patients); (6) bacterial sepsis (6%, 5 patients); (7) chronic or recurrent atrial arrhythmia (5%, 4 patients); and (8) glycogen or mucopolysaccharide storage (2.5%, 2 patients).
There were 24 patients who met study entrance criteria for idiopathic cardiomyopathy and myocarditis (Table 1) . Thirteen patients were boys and 11 were girls. The age at presentation ranged between 1 day and 1.67 years with a mean of 0.44±0.46 year and a median age of presentation of 0.34 year. All patients presented with clinical signs of congestive heart failure. No patients had a family history suggestive of familial cardiomyopathy. Five of 24 were febrile at presentation, 4 of whom had biopsy findings consistent with myocarditis. Of the 19 chest radiographs that were obtained at the time of presentation, 16 were interpreted as demonstrating moderate to severe cardiomegaly, and 3 were interpreted as demonstrating mild cardiomegaly. ECGs at the time of presentation were available in 22 of the patients, and all had abnormal repolarization patterns. Eight patients had left ventricular hypertrophy on ECG (3 with endocardial fibroelastosis [EFE] on myocardial biopsy, 4 with normal or nonspecific findings on biopsy, and 1 with no biopsy). Abnormally small QRS complexes were found in 2 patients, both of whom were believed to have myocarditis. Three patients had ventricular tachycardia during the first admission, 2 of whom had myocarditis. In the patients who had successive biopsies, 1 had a definite diagnosis of myocarditis in his first biopsy, whereas the second and third biopsies (3 and 7 months after the first biopsy) showed only nonspecific changes, including focal fibrosis and hypertrophic changes. In the other patient with serial biopsies, the first biopsy showed borderline myocarditis (myocardial edema and mild lymphocytic infiltrate but no myonecrosis), and later biopsies revealed only focal interstitial fibrosis (3 and 7 months after the first biopsy).
Clinical Outcome
There were seven deaths (29%), with all except one occurring less than 2 months after presentation. In three cases (patients 1, 22, and 24), death occurred within hours of presentation, and this included both patients with carditis who died. The three early deaths occurred in patients from the immediate area, whereas 9 of 21 of the other patients were from geographically remote locations. This implies that selection bias is likely, such that the patients included in this study were already selected for longer survival. Three of the 4 patients who died more than 1 week after presentation (patients 12, 16, 17, and 20) had a tissue diagnosis of EFE. In 2 patients, a LV thrombus was documented by echocardiography during the acute phase of the disease. In no instance was there clinical evidence of embolic phenomena. In the 17 survivors followed for 1 to 7.5 years, 11 regained normal LV function (LV ejection fraction, >51%), 4 have persistent LV dysfunction (LV ejection fraction, <47%), and 2 are symptomatic. Follow-up ejection fraction was not available in the 2 survivors with a tissue diagnosis of EFE, but both are asymptomatic.
Relation of Outcome to Pathology
The relation of tissue diagnosis to outcome is displayed in Table 2 . Tissue diagnosis of EFE was associated with poorer survival, with death in 4 of the 6 patients with EFE. Of the 8 patients with tissue diagnosis of myocarditis (6 patients with definite and 2 with borderline myocarditis on biopsy), 2 died. Four of the patients (3 with definite and 1 with borderline myocardiwith postmortem tissue examination, previous endomyocardial biopsies had not been performed. In 35 -+±10% at presentation, whereas the 9 with poor outcome (patients who died or in whom LV dysfunction persisted) had an initial LV ejection fraction of 17+7% (Fig 1, P=.0004 ). When examined with respect to survival, the initial mean LV ejection fraction of the 15 survivors was 29±11%, whereas the LV ejection fraction in the 6 who died was 16±8% (P=.02). There (Table 3) .
Patterns of Recovery of LV Function
For 24 patients, a total of 68 echocardiograms were available at various times following presentation that had adequate data for analysis of LV function by two-dimensional echocardiography, M-mode, or both. The data (from two to five echocardiograms per patient) were pooled to examine the trends in LV size, function, and contractility over time. These trends are illustrated in Figs 3 through 6. Body surface area-adjusted EDV fell rapidly over the first several months of observation, with little change thereafter (Fig 3) . LV mass (adjusted for body surface area), which was generally elevated from the earliest observations, followed a similar pattern although the rate of fall was more gradual (Fig 4) . As a result, the mass-to-volume ratio (normally 1.0) was elevated in most patients even at the time of first observation and fell gradually to the normal range over the first 2 years after presentation before a plateau was attained (Fig 5) . Ejection fraction returned to normal within days to weeks in some individuals, but for the group it improved more gradually, with a plateau in the recovery after about 2 years (Fig 6) . Contractility, assessed as the SVI (Fig 7) , was noted to follow a trend similar to the pattern for ejection fraction, demonstrating a stable range after about 2 years. Thus, although EDV fell rapidly after presentation, perhaps in part due to medical therapy, mass, systolic function, and contractility normalized more slowly. Discussion In this review of patients with DCM presenting before 2 years of age, tissue evidence of myocarditis was Plot of evolution of the ratio of left ventricular mass to volume (MVR) in g/mL after presentation. Perhaps surprisingly, the MVR was normal or elevated from the time of the earliest observations. Due to the more rapid fall in volume than mass, the normalization of MVR was prolonged, approaching the normal value of 1.0 at about 2 years after initial presentation.
found in 45% and was associated with a better prognosis, whereas tissue evidence of EFE, present in 25%, carried a worse prognosis. Overall, outcome in this study was death in 30%, residual LV dysfunction in 20%, and complete recovery in 50%. We found clinical data to be relatively unreliable in diagnosing myocarditis. Death or recovery of function usually occurred in the first month after presentation, although some individuals experienced further improvement of ventricular function for as long as 2 years. Echocardiographic predictors of a worse outcome included the severity of ventricular dysfunction and a more spherical LV configuration. In those who recovered, the first event was a reduction in EDV with a rise in the mass-to-volume ratio and subsequent improvement in ejection fraction and contractility with normalization of mass and massto-volume ratio.
Myocarditis
In this group of young patients with idiopathic congestive cardiomyopathy, all presented with clinical signs 32 This phenomenon has also been described in myocardial injury secondary to prolonged volume overload, where the failure of the ventricular to maintain an ellipsoidal configuration with dilation is found in association with more severely depressed contractility.33,34 In a prior study of patients with volume-overloaded LV due to tricuspid atresia and other forms of single LV, we found that the transition to a more spherical ventricular shape was temporally associated with development of impaired contractility34 and with altered myocardial fiber orientation and similarly implied irreversibility of the myocardial injury.
Ventricular Mass-to-Volume Ratio
Prior clinical studies in adults with DCM have indicated that sustained ventricular hypertrophy with a more normal mass-to-volume ratio is associated with improved survival.28,35-37 For example, in one angiographic study, a mass-to-volume ratio <0.9 was found to be associated with higher mortality. 38 The patients in this study had a nearly normal mass-to-volume ratio even at the time of first presentation, in contrast to the reduced mass-to-volume and thickness-to-dimension ratio that are typical of adults with DCM.28 It is known from animal and human studies that the immature myocardium has an enhanced hypertrophic capacity in response to increased wall stress.39-41 It is possible that this property, whether it represents hyperplasia or true hypertrophy, could contribute to the apparently better survival in DCM in the infant and young child.
Hemodynamic Variables
In our study, hemodynamic parameters such as right atrial pressure, pulmonary artery pressure, LV end-diastolic pressure, and cardiac index were not predictive of outcome. However, these hemodynamic variables were measured in only 3 of the 7 patients who died. Perhaps more important, the hemodynamic data were obtained at a median of 6 days after presentation. Therapeutic interventions had been undertaken in all, and it is likely that the administration of cardiotonic agents and vasodilators would have substantially altered these hemodynamic parameters.
Recovery of Ventricular Function
Improvement was rapid in many patients and followed a pattern of improved function, reduced diastolic volume, but slower reduction in ventricular mass with a consequent rise in the mass-to-volume ratio. The time course of recovery was usually within 1 or 2 months, although there were two instances of sustained recovery for as long as 2 years after presentation. However, even in these latter cases, there was some improvement in function within the first 2 months. In those instances where measures of contractility could be obtained, improvement in contractility followed a parallel but somewhat delayed course and never preceded the reduction in EDV or improved systolic function.
Conclusions
In children <2 years of age presenting with DCM cardiomyopathy of unknown cause, (1) the overall mortality is about 30%; patients with inflammatory changes on biopsy have a better outcome than do those with histological evidence of EFE; (2) the clinical diagnosis of myocarditis is unreliable and EFE is primarily a histological diagnosis, underscoring the need for biopsy; (3) death or recovery usually occurs early after presentation; (4) indicators of a poor prognosis at presentation include severe ventricular dysfunction, more spherical ventricular configuration, and evidence of EFE on histology; (5) in contrast to older patients, most had a normal mass-to-volume ratio, even at first presentation; and (6) with recovery, the rate of decrease in volume exceeds the reduction in mass, and although function returns to normal usually after a few months, the mass-to-volume ratio can remain high for more than 1 year, returning more slowly to normal.
